OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 431 - 440 of 695 studies

Cancer and neoplasms

THE SCOTTY STUDY - whole genome sequencing of young colon cancer patients and their parents. (Muskateer)

Cancer of the large bowel (colorectal cancer) is common in the general population and the lifetime risk for someone living in the UK is 1 in 17. Whilst modern surgery, radiotherapy and chemotherapy treatments have impacted beneficially on survival outcome, many patients still die from their disease. Hence, there is a pressing need to understand the causes of colorectal cancer and to intervene early. Colorectal cancer under the age of 40 years of age is particularly rare, with less than 1.2% of all ...

GO TO STUDY Go

Eye

A NATURAL HISTORY OBSERVATION AND REGISTRY STUDY OF MACULAR TELANGIECTASIA TYPE 2 THE MACTEL STUDY

Macular Telangiectasia (MacTel) type 2 is a disease of the retina, the light-sensing tissue at the back of the eye. MacTel type 2 leads to a gradual deterioration of central vision,which usually becomes noticeable in people around 40 to 60 years of age.The gradual loss of central vision experienced because of MacTel type 2 has a significant impact on quality of life, due to central vision being required for tasks that require sharp vision,e.g. reading and driving. MacTel type 2 ...

GO TO STUDY Go

Inflammatory and immune system

Prognosis of Temporal Arteritis

We will examine the natural history of a condition called temporal arteritis (also called Giant Cell Arteritis - GCA) over 10 years in order to identify risk factors associated with more severe disease. GCA is a condition involving inflammation of blood vessels (we call this “vasculitis”). It usually affects arteries around the head area. It causes narrowing and sometimes blockage of some of these vessels. It can cause severe headache and may cause blindness. Treatment consists of high doses of ...

GO TO STUDY Go

Generic health relevance

Rare and Undiagnosed Diseases Study (RUDY)

Rare diseases have a significant impact on quality of life and are difficult to diagnose because of their variety and rarity. Each has a differing impact on both the patient and the NHS. There is an urgent need to improve the care of these patients by developing novel diagnostic tests and therapies. More detailed phenotyping of groups of patients with rare diseases would lead to improved predictive, diagnostic and therapeutic measures. This application is to develop a national ...

GO TO STUDY Go

Neurological

Oxford study of quantification in parkinsonism

Most medical conditions can be rapidly and accurately quantified. For example we can accurately measure the airflow rate in the lungs in asthma or the degree of narrowing of arteries in heart disease. However, we still measure many brain diseases using a clinical rating scale, a system of points assigned by an observer based on their impression of the person's condition. Such scales are subjective, i.e. two different people assessing the same patient may not score the patient ...

GO TO STUDY Go

Inflammatory and immune system Reproductive health and childbirth

HYPATIA: A prospective randomised controlled trial of HYdroxychoroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibodies

Patients with antiphospholipid antibodies (aPL) may have an increased risk of having blood clots and women with aPL may have problems during pregnancy. In the presence of aPL blood becomes more ‘sticky’ than usual. aPL occur in about 1% of the population. Knowing that there are 800,000 births a year in the United Kingdom, this means 8,000 pregnancies affected by aPL every year. Women with aPL are more likely to have pregnancy loss and/or small babies and/or pre-eclampsia (high blood ...

GO TO STUDY Go

Respiratory

Measurement of novel indices of lung function in respiratory disease

Currently,respiratory disorders are diagnosed,assessed or monitored using lung function measurements provided by forced spirometry. Spirometric measures have some limitations including: being effort- and technique-dependent and not being sensitive to early changes in the lung,meaning their utility in diagnosis early lung disease or monitoring disease progression or treatment effects is limited. Our research team has developed a new method for measuring lung function which involves assessing inhomogeneity (unevenness) in gas-exchange in the lung. This is based on two advances: a gas ...

GO TO STUDY Go

Cardiovascular

Childhood Hypertrophic Cardiomyopathy: A new risk stratification tool

Childhood cardiomyopathies are associated with an increased risk of arrhythmias,heart failure and sudden death and it remains challenging to identify those at highest risk Principle research question: Can we identify patients with childhood onset dilated cardiomyopathy at risk of adverse events? Methodology: This is an international multicentre study. Collaborating centres will identify eligible patients and collect serial routine anonymised,retrospective clinical and imaging data as assessed at the time of first evaluation,follow up and last evaluation. Anonymised data will be entered into a secure ...

GO TO STUDY Go

Congenital disorders

Genetics of Perrault Syndrome (hearing loss and ovarian insufficiency) (Muskateer)

Perrault syndrome (PS) is a very rare genetic condition which displays symptoms of deafness and/ or ovarian problems. Other features such as peripheral neuropathy and mild mental retardation have also been reported. We want to see if we can identify any further genes that may play a role in PS. This may help to confirm a diagnosis for individuals showing some features of the syndrome allowing them to access appropriate genetic counselling and help to identify the risk for ...

GO TO STUDY Go

Blood Cancer and neoplasms

INvestigating the genetic and cellular basis of sporadic and Familial Myeloid Disorders’ – the INForMeD Study.

This research project will study the genetic and cellular basis of sporadic and familial myeloid disorders. Myeloid disorders are haematological (blood related) medical conditions that can have a significant negative impact upon patients in terms of both quality and length of life. Research is required to enhance our understanding of these conditions so that we can better determine how these types of disorder may develop, thereby improving diagnoses and treatment. Professor Mead’s research team at the University of Oxford is ...

GO TO STUDY Go